AU2178497A - Cephem compounds and drugs containing the compounds - Google Patents

Cephem compounds and drugs containing the compounds

Info

Publication number
AU2178497A
AU2178497A AU21784/97A AU2178497A AU2178497A AU 2178497 A AU2178497 A AU 2178497A AU 21784/97 A AU21784/97 A AU 21784/97A AU 2178497 A AU2178497 A AU 2178497A AU 2178497 A AU2178497 A AU 2178497A
Authority
AU
Australia
Prior art keywords
optionally substituted
compounds
single bond
substituted lower
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21784/97A
Other languages
English (en)
Inventor
Koji Ishikura
Yasuhiro Nishitani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2178497A publication Critical patent/AU2178497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AU21784/97A 1996-04-04 1997-04-04 Cephem compounds and drugs containing the compounds Abandoned AU2178497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8253196 1996-04-04
JP8-82531 1996-04-04
PCT/JP1997/001161 WO1997037996A1 (en) 1996-04-04 1997-04-04 Cephem compounds and drugs containing the compounds

Publications (1)

Publication Number Publication Date
AU2178497A true AU2178497A (en) 1997-10-29

Family

ID=13777098

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21784/97A Abandoned AU2178497A (en) 1996-04-04 1997-04-04 Cephem compounds and drugs containing the compounds

Country Status (11)

Country Link
US (2) US6214818B1 (enExample)
EP (3) EP1671966A1 (enExample)
JP (1) JP4064462B2 (enExample)
KR (1) KR20000005238A (enExample)
CN (2) CN1088711C (enExample)
AT (1) ATE341554T1 (enExample)
AU (1) AU2178497A (enExample)
CA (1) CA2250002C (enExample)
DE (1) DE69736775T2 (enExample)
ES (1) ES2273364T3 (enExample)
WO (1) WO1997037996A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022469A1 (en) * 1996-11-22 1998-05-28 Meiji Seika Kaisha, Ltd. Cephem intermediates and process for producing the same
EP1394159A1 (fr) * 2002-08-13 2004-03-03 Warner-Lambert Company LLC Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JP3928086B2 (ja) * 2005-03-29 2007-06-13 塩野義製薬株式会社 ３−プロペニルセフェム誘導体
CA2658764A1 (en) * 2006-07-20 2008-01-24 Mehmet Kahraman Benzothiophene inhibitors of rho kinase
CN101153028B (zh) * 2006-09-30 2010-12-15 山东轩竹医药科技有限公司 具有抗菌抗病毒活性的化合物
TWI574957B (zh) 2011-07-29 2017-03-21 佳佑製藥治療公司 含有醯肼的核運輸調控子及其用途
WO2013019561A1 (en) * 2011-07-29 2013-02-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP3616695B1 (en) 2011-09-09 2024-10-23 Merck Sharp & Dohme LLC Ceftolozane/tazobactam for treating intrapulmonary infections
RS58058B1 (sr) 2012-05-09 2019-02-28 Biogen Ma Inc Modulatori nukleusnog transporta i njihove upotrebe
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US10202366B2 (en) 2013-03-15 2019-02-12 Karyopharm Therapeutics Inc. Methods of promoting wound healing using CRM1 inhibitors
EP2893929B1 (en) 2013-03-15 2025-04-16 Merck Sharp & Dohme LLC Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
DK3010892T3 (en) 2013-06-21 2019-04-15 Karyopharm Therapeutics Inc 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND APPLICATIONS THEREOF
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
EP3397633A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
WO2017117535A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5271239A (en) * 1975-12-10 1977-06-14 Matsushita Electric Ind Co Ltd Electron beam sensitive material
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
JPS6064988A (ja) * 1983-09-21 1985-04-13 Sankyo Co Ltd セフアロスポリン誘導体
JPS60237090A (ja) * 1984-02-21 1985-11-25 Takeda Chem Ind Ltd セフエム化合物
GB8520155D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Compounds
JPS62158290A (ja) * 1985-12-28 1987-07-14 Banyu Pharmaceut Co Ltd 新規セフアロスポリン誘導体
JPS62158291A (ja) * 1986-01-07 1987-07-14 Sagami Chem Res Center セフアロスポリン誘導体
JPH0459730A (ja) * 1990-06-26 1992-02-26 Dai Ichi Seiyaku Co Ltd セフェム系抗生物質含有凍結乾燥製剤
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
JPH05217239A (ja) * 1991-10-31 1993-08-27 Sony Corp 光磁気ディスク記録再生装置
EP0554004A3 (en) * 1992-01-27 1993-11-24 Katayama Seisakusho Cephem compounds and antibacterial agents
JPH0741485A (ja) * 1993-07-30 1995-02-10 Katayama Seiyakushiyo:Kk セフェム誘導体およびそれを含有する抗菌剤

Also Published As

Publication number Publication date
EP0893446A1 (en) 1999-01-27
EP0893446A4 (enExample) 1999-01-27
CA2250002C (en) 2008-03-25
DE69736775D1 (de) 2006-11-16
ATE341554T1 (de) 2006-10-15
ES2273364T3 (es) 2007-05-01
EP1671966A1 (en) 2006-06-21
EP0893446B1 (en) 2006-10-04
KR20000005238A (ko) 2000-01-25
CA2250002A1 (en) 1997-10-16
JP4064462B2 (ja) 2008-03-19
CN1215403A (zh) 1999-04-28
DE69736775T2 (de) 2007-08-23
CN1088711C (zh) 2002-08-07
CN1129596C (zh) 2003-12-03
CN1290702A (zh) 2001-04-11
EP1544197A1 (en) 2005-06-22
US6214818B1 (en) 2001-04-10
US6458950B1 (en) 2002-10-01
WO1997037996A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
AU2178497A (en) Cephem compounds and drugs containing the compounds
MY118904A (en) 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents
CA2418125A1 (en) Beta-lactams useful in the preparation of substituted isoserine esters
AU7077894A (en) Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
HUP0100270A2 (hu) Eljárások és vegyületek béta-amiloid peptid kibocsátás és/vagy szintézisgátló peptidek, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NZ297661A (en) Hindered N-oxide esters of rapamycin and pharmaceutical compositions
CA2680292A1 (en) Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
CA2219675A1 (en) Pentacyclic compound
AU3744397A (en) Total synthesis of antitumor acylfulvenes
ES2122258T3 (es) 4-azaesteroides 15 sustituidos.
EP1184373A4 (en) TRICYCLIC CONNECTIONS
EP0467647A3 (en) Thioalkylthio cephalosporin derivatives
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
IL121842A0 (en) Heterobicyclic compounds
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
EP0469156A4 (en) Glutathione derivative
CA2089368A1 (en) Antibacterial penem esters derivatives
AU4679189A (en) Naphthalene derivatives
DE69902416D1 (de) Dihydro- oder Tetrahydronaphthalenderivate mit (anti)estrogenen Eigenschaften
EP1074545A4 (en) ISOCHINOLINE SULPHONAMIDE DERIVATIVES AND MEDICINES CONTAINING IT AS AN ACTIVE INGREDIENT
MY106839A (en) Carboxylate compounds, liquid crystal compositions containing said compounds and liquid crystal elements.
ES2168189A1 (es) Derivados de piperazinona
ZA953391B (en) 3-substituted pyridine compounds and derivatives thereof
CA2027542A1 (en) Uv-absorbing cyclic enaminoketones
AU7589494A (en) Pyrrolidine derivatives